Isoalantolactone Increases the Sensitivity of Prostate Cancer Cells to Cisplatin Treatment by Inducing Oxidative Stress

Prostate cancer is the most common malignancy among men worldwide. Platinum (II)-based chemotherapy has been used to treat a number of malignancies including prostate cancer. However, the potential of cisplatin for treating prostate cancer is restricted owing to its limited efficacy and toxic side e...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Hang, Li, Ping, Ye, Xueting, Zhang, Fangyi, Lin, Qi, Wu, Keming, Chen, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093765/
https://www.ncbi.nlm.nih.gov/pubmed/33959604
http://dx.doi.org/10.3389/fcell.2021.632779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093765/
https://www.ncbi.nlm.nih.gov/pubmed/33959604
http://dx.doi.org/10.3389/fcell.2021.632779

Ejemplares similares